Delivery Order SPE2DR25D9238-SPE2DR26FRRD6
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $6,224.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, with a period of performance through April 2, 2024. This delivery order is issued against DMS Pharmaceutical Group's larger indefinite delivery vehicle (IDV) contract SPE2DB, valued up to...
- The Defense Logistics Agency awarded a delivery order valued at $5,966.88 to DMS Pharmaceutical Group Inc. for VABYSMO 6 mg/0.05 mL syringes on October 29, 2025. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The product will be delivered to Park Ridge, Illinois, with an ultimate completion date of November 20,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain division on October 17, 2025, for VABYSMO 6 mg/0.05 ml syringes valued at $5,966.88 with a firm fixed-price structure. The delivery order, which carries no set-aside designation, is issued under DMS Pharmaceutical Group's broader Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V)...
- The U.S. Defense Logistics Agency (DLA) awarded a $6,224.44 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with DLA under the SPE2DB program. The IDC enables DLA to issue delivery orders for a wide range of pharmaceutical items to support the recurring medical supply needs of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,546.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of SYFOVRE 15 mg/0.1 mL vials. The award, issued on October 16, 2025, with an ultimate completion date of November 6, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,916.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of VABYSMO 6 mg/0.05 ml vials. The delivery order, issued on November 3, 2025, with an ultimate completion date of November 25, 2025, utilizes firm fixed-price pricing with no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. This...
- The Defense Logistics Agency awarded a $8,950.32 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of VABYSMO 6 mg/0.05 ml syringes. The contract was awarded on July 29, 2025, with an ultimate completion date of August 19, 2025, and carries no set-aside designation. DMS Pharmaceutical Group will perform the delivery order from its Park Ridge facility. This delivery order is issued...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,224.44 contract is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC allows the DLA to issue...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,983.44 by the Defense Logistics Agency (DLA) on June 2, 2025. The contract calls for the delivery of Vabysmo 6 mg/0.05 mL syringes (0.05 mL) with an ultimate completion date of June 24, 2025. This delivery order was issued without a set-aside designation and represents a single-line procurement of this pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,966.88 by the Defense Logistics Agency on August 26, 2025. The delivery order covers VABYSMO 6 mg/0.05 mL syringes, a prescription pharmaceutical product, with an ultimate completion date of September 17, 2025. This award was not issued under a set-aside designation, allowing the vendor to compete directly in the open...
- SPE2DR25D9238Indefinite Delivery Contract
- SPE2DR25D9238-SPE2DR26FRRD6Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,089.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for supply of VABYSMO 6 mg/0.05 mL syringes. This firm fixed-price delivery order, issued on November 13, 2025, with an ultimate completion date of December 5, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award was funded by the DLA and executed without identified subcontractors. This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated contract SPE2DR. The IDC, valued at $499,999,999 with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a regional prime vendor contractor within the $30.3 billion PPV-G GEN V acquisition strategy designed to support recurring pharmaceutical and medical supply needs across Department of Defense healthcare facilities worldwide. The underlying IDC structure enables the DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, biologics, and medical consumables to support military medical operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 11/13/25 |